GENOMIC VISION news, videos and press releases
For more news please use our advanced search feature.
GENOMIC VISION - More news...
GENOMIC VISION - More news...
- Genomic Vision Launches HexaCard, a New Service for Characterizing Transformed Cell Lines
- Genomic Vision Announces the Issuance of the 3rd Tranche of Convertible Notes With Warrants (OCABSA) for €2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €30 Million
- Genomic Vision Enters Distribution Agreement with CliniSciences
- Genomic Vision Enters Technology Agreement With The Institute of Cancer Research, London
- Genomic Vision Provides Strategy Update
- Genomic Vision: Financial Information for the First Quarter of 2023
- Genomic Vision: 2022 Annual Results
- Genomic Vision Joins France BioLead to Advance Innovation and Production of Biopharmaceuticals in France
- Genomic Vision launches FiberSmart®, AI-powered software for automating genomic analysis
- Genomic Vision: Financial Information for the Fourth Quarter of 2022
- The US National Institute of Standards and Technology (NIST) has evaluated the use of Genomic Vision applications for genetic variant characterization
- The US National Institute of Standards and Technology (NIST) has evaluated the use of Genomic Vision applications for genetic variant characterization
- Genomic Vision announces the issuance of the 2nd tranche of convertible notes with warrants (OCABSA) for €2 million, as part of the financing line concluded with Winance for a maximum amount of €30 million
- Genomic Vision Strengthens Leadership Team With the Appointment of Frederic Hammel as Chief Operating Officer
- Genomic Vision Announces Successful Beta Testing of FiberSmart®
- Genomic Vision’s Cutting-Edge TeloSizer® Application to be Used in Cancer Research
- Genomic Vision and Cambridge Consultants, Part of Capgemini, Announce the Development of an Innovative Technology Platform for In-depth Genomic Analysis
- Genomic Vision: Financial Information for the Third Quarter of 2022
- Genomic Vision: Press Release Regarding Changes in the Company’s Governance
- Genomic Vision: First-half 2022 Results
- Genomic Vision Announces the Issuance of the 1st Tranche of Convertible Notes With Warrants (OCABSA) for €2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €30 Million
- Genomic Vision: Financial Information for the First Half of 2022
- Genomic Vision: Additional Contribution to the Liquidity Contract Concluded with CM-CIC Securities
- Genomic Vision: Changes in the Company’s Governance
- Genomic Vision Obtains the Renewal of the ISO 13485 : 2016 Certification
- Genomic Vision granted a new patent for its “Physical Characterization of Telomeres” technique based on molecular combing
- Genomic Vision Announces the Approval by Its Shareholders’ Meeting of All the Resolutions Supported by the Executive Board
- Genomic Vision Announces the Signing of an Addendum to the Contract Signed with Winance on April 11, 2022 for the Purpose of Implementing a New Financing Line, Subject to the Prior Approval of the Company’s Shareholders
- Genomic Vision: Financial Information for the First Quarter of 2022
- Genomic Vision: 2021 Annual Results
